AEGiS-IRIN: New Deadline for Free Anti-Retrovirals UN Integrated Regional Information NetworkImportant note: Information in this article was accurate in 2003. The state of the art may have changed since the publication date.
Click here to return to UN Integrated Regional Information Network main menu
DonateNow




New Deadline for Free Anti-Retrovirals

Integrated Regional Information Networks - December 2, 2003


Uganda's ministry of health on Monday committed itself to offering free antiretroviral (ARV) treatment to HIV/AIDS sufferers who urgently need it but cannot afford it, starting January 2004.

The announcement was made at the World AIDS Day commemoration in Kampala, attended by President Yoweri Museveni and Health Minister Jim Muhwezi.

In the government's firmest commitment to date to providing access to the drugs, Muhwezi said that from January, Uganda would be the second country in Africa after Botswana to give free ARV drugs to its people living with HIV/AIDS.

However, he stressed that priorities would have to be drawn up.

"We are initially giving these drugs to orphans and pregnant mothers to prevent mother to child transmission," Muhwezi said. "Much still depends on how low the prices of the drugs go. Not long ago, treatments for one month were US $500 - now they are US $27.50."

Last month, Uganda received US $66 million for AIDS treatment and care under the Global Fund to fight AIDS, TB and Malaria.

Muhwezi told IRIN that, in addition, Uganda has already procured US $6 million from the Bush administration and is expecting a great deal more under President Bush's pledge of US $15 billion to 12 African countries to help combat the disease.

However, Muhwezi added it was not yet clear whether money from the Bush fund would be used to buy generics, or whether the US would insist on the purchase of patented drugs from the big brands which are 20 times more expensive.

Uganda has an estimated 150,000 people in need of ARV drugs, only about 10,000 of whom have access to them at present.

"Four regional centres for distribution and monitoring progress of the ARV drugs are already operational," Muhwezi said. "And we are expecting to have a lot more early next year."


031202
IR031215


Copyright © 2003 - Integrated Regional Information Networks (IRIN). Reproduction of this article (other than one copy for personal reference) must be cleared through the Integrated Regional Information Network. .

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980 – 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .